0001739426-23-000003.txt : 20230831
0001739426-23-000003.hdr.sgml : 20230831
20230831142321
ACCESSION NUMBER: 0001739426-23-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230831
DATE AS OF CHANGE: 20230831
EFFECTIVENESS DATE: 20230831
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RVL Pharmaceuticals plc
CENTRAL INDEX KEY: 0001739426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-491138
FILM NUMBER: 231228351
BUSINESS ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 9088091300
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Osmotica Pharmaceuticals plc
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: Osmotica Pharmaceuticals Ltd
DATE OF NAME CHANGE: 20180502
D
1
primary_doc.xml
X0708
D
LIVE
0001739426
RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
908-809-1300
IRELAND
Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals Ltd
Other
IRISH LIMITED COMPANY
true
JOAQUIN
BENES
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Director
GREGORY
COWAN
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Director
MICHAEL
DEBIASI
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Director
ALISA
LASK
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Director
BRIAN
MARKISON
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Executive Officer
Director
JUAN
VERGEZ
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Director
JAMES
SCHAUB
C/O RVL Pharmaceuticals plc
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
NEW JERSEY
08807
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-08-18
false
true
true
false
0
H.C. WAINWRIGHT & CO., LLC
375
None
None
430 PARK AVENUE
4TH FLOOR
NEW YORK
NY
NEW YORK
10022
NY
NEW YORK
false
5000000
5000000
0
false
1
812500
0
0
false
RVL Pharmaceuticals plc
BRIAN MARKISON
BRIAN MARKISON
CHIEF EXECUTIVE OFFICER
2023-08-31